1-4 of 4
Michael E Coyle, MD
Close
Sort by
Journal Articles

Buparlisib/BKM120 PI3 Kinase Therapy in B Cell and T Cell Non-Hodgkin Lymphoma (NHL) and Hodgkin Lymphoma (HL): Identification of Resistance Pathways and Biomarker Discovery

Afshin Beheshti, PhD, Michael E Coyle, MD, Ravi Dashnamoorthy, PhD, Andrew M Evens, DO, MSc, FACP
Journal: Blood
Blood (2016) 128 (22): 2920.
https://doi.org/10.1182/blood.V128.22.2920.2920
Published: 2016
Journal Articles

The Proteasome Inhibitor, Ixazomib, Combined with Novel Drug Combinations in T-Cell Lymphoma (TCL) and Hodgkin Lymphoma (HL): Identification of Key Genes and Signaling Pathways Via a Novel Systems Biology Approach

Frank C. Passero, Jr., MD, Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, Lynn Hlatky, PhD, Nassera Abermil, MS, PharmD, Michael E Coyle, MD, Jaya Sharma, MD MBBS, Andrew M. Evens, DO, MSc
Journal: Blood
Blood (2015) 126 (23): 2753.
https://doi.org/10.1182/blood.V126.23.2753.2753
Published: 2015
Journal Articles

The PI3 Kinase (PI3K) Inhibitor, Buparlisib/BKM120, in B-Cell, T-Cell and Hodgkin Lymphoma Cell Lines: Cell Death Studies and Examination of Genomic Pathway Analyses Via a Systems Biology Approach

Michael E Coyle, MD, Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, Andrew M. Evens, DO, MSc
Journal: Blood
Blood (2015) 126 (23): 1555.
https://doi.org/10.1182/blood.V126.23.1555.1555
Published: 2015
Journal Articles

Improvements in Patient Outcomes with Autologous Stem Cell Transplantation for Multiple Myeloma over 25 Years at a Single Center

Sandy W. Wong, MD, Melissa Warner, BS, Alejandro Moreno-Koehler, MPH, Athena Kritharis, MD, Michael E Coyle, MD, Deborah Black, RN, BSN, Valerie Relias, PharmD, BCOP, Terry Fogaren, RN, BSN, Nancy Cody Lyons, NP, Francois Toka, NP-C, Denise Larivee, RN, Hedy Smith, MD PhD, Andrew M. Evens, DO, MSc, Grace Kao, MD, Kellie Sprague, MD, Andreas K. Klein, MD, Kenneth B. Miller, MD, Raymond L. Comenzo, MD
Journal: Blood
Blood (2015) 126 (23): 5496.
https://doi.org/10.1182/blood.V126.23.5496.5496
Published: 2015